Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Level 3 - non-randomized controlled study
Non-randomized retrospective comparative cohort study
PubMed 34826623 · doi:10.1016/j.cmi.2021.11.010
What was done
A multicentre retrospective cohort study in Singapore compared 218 hospitalized patients infected with SARS-CoV-2 B.1.617.2 (Delta). Clinical outcomes, PCR cycle threshold kinetics, and serological responses (anti-nucleocapsid, anti-spike, and surrogate virus neutralization titres) were compared between fully vaccinated mRNA recipients and unvaccinated individuals.
What was found
Of 218 patients with Delta infection (71 fully vaccinated with mRNA vaccines, 130 unvaccinated), severe COVID-19 requiring oxygen supplementation occurred in 2.8% (2/71) of fully vaccinated patients versus 53.1% (69/130) of unvaccinated patients (p < 0.001). The adjusted odds ratio for severe disease in vaccinated individuals was 0.07 (95% CI 0.015-0.335, p = 0.001). Initial PCR cycle threshold values at diagnosis were similar between groups, but viral loads decreased faster in vaccinated patients. Vaccinated individuals exhibited rapid boosting of anti-spike antibodies, though neutralization titres were lower against Delta than the wildtype strain.
Why it matters
The study shows that while initial viral loads in Delta infections are similar regardless of vaccination status, mRNA vaccination promotes faster viral clearance and significantly reduces progression to severe disease.
Limits
The study is limited by its retrospective observational design, modest sample size (n = 218 total, 71 fully vaccinated), and restriction to hospitalized individuals, omitting mild non-hospitalized or asymptomatic cases.
Cited by
- supports A preprint study from Singapore showed that although initial viral loads were similar, vaccinated patients with Delta breakthrough infections cleared the virus faster (achieved a negative PCR faster) than unvaccinated patients.